Nano-Strategies in Fighting Cancer
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 20 February 2025 | Viewed by 2682
Special Issue Editors
Interests: nanomedicines; cancer; cell mechanics; mechanobiology; biosensor; microfluidic; biomaterials; POC diagnostic devices; intracellular plasmonic
Interests: nano-bio interactions; biosensors; optical BIoMEMS
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleague,
Despite numerous technological advancements in cancer detection and treatment, global cancer management still encounters challenges in achieving efficiency. Over the past two decades, the field of nanotechnology has facilitated the emergence of the nano-bio interaction domain, enhancing our understanding of how nano-sized particles interact with the biological environment. While significant progress has been made in developing more efficient treatment approaches for enhanced cancer management within this field, many aspects remain understudied. For instance, although the biophysical properties of cells, such as cell mechanics, have been extensively examined for their roles in cancer progression and metastasis, their relevance in the context of nano-bio interaction and the development of nanotools for cancer management have not been thoroughly investigated. Due to the small size of nanoparticles, they have the potential to interact with cytoskeleton components, thereby impacting cell functionality by altering mechanobiological responses. In this sense, the physicochemical properties of nanoparticles can be modified to potentially target cell mechanobiology, in addition to their other intended therapeutic purposes, for increased effectiveness. This precision allows for the control of critical functions, including migration, adhesion, and invasion, which are the key drivers of metastasis.
This Special Issue serves as a platform to showcase research papers and reviews that highlight recent developments in using nanoparticles to enhance cancer management. For instance, this includes targeting the biophysical properties of cancer cells for more effective treatment or improving cancer diagnosis through the development of sensitive and innovative methods. Through this multidisciplinary exploration, our aim is to advance our understanding of how nanoparticles can revolutionize cancer management and identify future directions that will lead to innovative solutions for persistent challenges in cancer management.
Dr. Ahmad Sohrabi Kashani
Prof. Dr. Muthukumaran Packirisamy
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicines
- targeted therapy
- intracellular diagnosis
- cell mechanics
- nano-biosensor
- nano-bio interaction
- mechanobiology
- nano-biomechanics
- drug delivery
- migration
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
